Want to join the conversation?
$CTL expects 4Q15 operating revenues in the range of $4.40-4.45Bil and operating cash flow in the range of $1.72-1.77Bil, which are lower when compared to 3Q15, primarily driven by the retroactive recognition of CAF Phase 2 funds in 3Q15. Further, the company anticipates its adjusted diluted EPS to be in the range of $0.62-0.67 for 4Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?